CanSino Biologics Inc. (CASBF)
OTCMKTS · Delayed Price · Currency is USD
5.98
0.00 (0.00%)
At close: Sep 2, 2025
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of $2.28 billion as of September 9, 2025. Its market cap has increased by 132.68% in one year.
Market Cap
2.28B
Enterprise Value
2.09B
Revenue
129.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.98
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 964.53M to 2.28B, an increase of 136.85%. That is a compound annual growth rate of 14.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 2.32B | 54.94% |
| Dec 31, 2024 | 1.49B | -6.53% |
| Dec 29, 2023 | 1.60B | -54.97% |
| Dec 30, 2022 | 3.55B | -58.11% |
| Dec 31, 2021 | 8.48B | -11.66% |
| Dec 31, 2020 | 9.60B | 469.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 780.18M |
| Elite Pharmaceuticals | 742.62M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 372.66M |
| American Oncology Network | 345.48M |